• For Researchers

A vision for the next decade of UK life sciences

What could the government’s Life Sciences Vision mean for cancer research? What could the government’s Life Sciences Vision mean for cancer research?

21 July 2021

• Charity News

Charity ‘looks to the future with renewed optimism’

Cancer Research UK's Annual Report and Accounts 2020/21 reveals the impact of the pandemic on its income and spend on charitable activities over the past year. Cancer Research UK's Annual Report and Accounts 2020/21 reveals the impact of the pandemic on its income and spend on charitable activities over the past year.

21 July 2021

• Health & Medicine

One in 5 less likely to take part in cancer screening

A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic. A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.

16 July 2021

• Health & Medicine

American tobacco company offers £1bn for UK pharma firm Vectura

Philip Morris International (PMI), the American tobacco company, and maker of Marlboro cigarettes, is buying Vectura, the British respiratory drugs company. Philip Morris International (PMI), the American tobacco company, and maker of Marlboro cigarettes, is buying Vectura, the British respiratory drugs company.

9 July 2021

• For Researchers

Coming together for Zynlonta

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

2 July 2021

• Science & Technology

Genetic discovery could guide treatment for aggressive childhood cancer

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment. A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

28 June 2021

• Charity News

Race for Life events are back this autumn

Sign up to your local event and raise money to help beat cancer. Sign up to your local event and raise money to help beat cancer.

25 June 2021

• Health & Medicine

Men’s skin cancer rates increase by 50% over decade

Over the last 10 years, melanoma skin cancer among men in the UK has increased by almost 50%. Over the last 10 years, melanoma skin cancer among men in the UK has increased by almost 50%.

24 June 2021

• Health & Medicine

Cancer Research UK spin-out gets US approval to trial unique T-cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.   Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.  

18 June 2021

• Health & Medicine

Wales: 4 in 10 with possible cancer symptoms didn’t contact GP

New figures show 42.1% of people surveyed in Wales who experienced possible cancer symptoms in the first wave of the pandemic didn't contact their GP. New figures show 42.1% of people surveyed in Wales who experienced possible cancer symptoms in the first wave of the pandemic didn't contact their GP.

17 June 2021

• Health & Medicine

Fears breast cancer progress could stall due to COVID-19 backlog

Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow. Around 10,600 fewer breast cancer patients have started treatment in the last year in England, as experts fear hard-won progress could slow.

15 June 2021

• Health & Medicine

New hormone treatment for advanced prostate cancer made available in England

Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England. Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.

8 June 2021